From the Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong, Gangnam-gu, Seoul 135-710, Republic of Korea.
Radiology. 2014 Mar;270(3):768-76. doi: 10.1148/radiol.13130009. Epub 2013 Oct 30.
To assess the benefit of adding diffusion-weighted (DW) imaging to gadoxetic acid-enhanced magnetic resonance (MR) imaging and MR cholangiopancreatography in the preoperative evaluation of hilar cholangiocarcinoma.
The institutional review board approved this retrospective study and waived the requirement for informed consent. The study included 52 patients (36 men, 16 women; mean age, 63.4 years) with surgically confirmed hilar cholangiocarcinoma who underwent gadoxetic acid-enhanced MR imaging and DW imaging at 3.0 T between August 2010 and December 2011. Two observers independently reviewed two image sets--a gadoxetic acid set, including images from MR cholangiopancreatography, and a combined gadoxetic acid set and DW imaging set--to evaluate the tumor involvement of each biliary confluence and vascular and liver invasion by using receiver operating characteristic (ROC) curve analysis.
For each observer, area under the ROC curve (Az) values for tumor involvement of the biliary confluence were 0.965 and 0.957 for the gadoxetic acid set and 0.980 and 0.975 for the combined set, respectively (P > .05). For detecting 105 biliary confluences with tumor involvement, the sensitivities with the combined set (97.1% [102 of 105] and 98.1% [103 of 105]) were higher than those with the gadoxetic acid set (91.4% [96 of 105] for both observers) (P = .029 and P = .016), although the specificities were similar with both image sets (P > .05). For the detection of liver invasion, the combined set (75.0% [15 of 20] for both observers) yielded better sensitivity than the gadoxetic acid set (50.0% [10 of 20] and 45.0% [nine of 20]) (P = .016 and P = .031). For evaluation of vascular invasion, the two image sets showed similar diagnostic performance.
In the preoperative evaluation of hilar cholangiocarcinoma, the addition of DW imaging to gadoxetic acid-enhanced MR imaging could improve sensitivity in the evaluation of tumor extent along the bile duct and liver invasion.
评估在术前评估肝门部胆管癌时,将扩散加权(DW)成像加入钆塞酸增强磁共振(MR)成像和 MR 胆胰管成像中的获益。
本回顾性研究经机构审查委员会批准,并豁免了知情同意书的要求。该研究纳入了 2010 年 8 月至 2011 年 12 月间在 3.0T 磁共振扫描仪上接受钆塞酸增强 MR 成像和 DW 成像的 52 例经手术证实的肝门部胆管癌患者(36 名男性,16 名女性;平均年龄,63.4 岁)。两位观察者分别独立地对两组图像(一套包括 MR 胆胰管成像的钆塞酸图像,以及一套联合的钆塞酸和 DW 成像)进行了评估,以使用受试者工作特征(ROC)曲线分析来评估每个胆管汇合处的肿瘤累及情况、血管和肝脏侵犯。
对于每位观察者,ROC 曲线下面积(Az)值用于评估胆管汇合处肿瘤累及情况时,钆塞酸组为 0.965 和 0.957,联合组为 0.980 和 0.975(P>.05)。对于检测 105 个有肿瘤累及的胆管汇合处,联合组的敏感度(两位观察者分别为 97.1%[102/105]和 98.1%[103/105])高于钆塞酸组(91.4%[96/105])(P=.029 和 P=.016),尽管两组的特异性相似(P>.05)。对于肝脏侵犯的检测,联合组(两位观察者均为 75.0%[15/20])的敏感度优于钆塞酸组(50.0%[10/20]和 45.0%[9/20])(P=.016 和 P=.031)。对于血管侵犯的评估,两种成像方法的诊断性能相似。
在术前评估肝门部胆管癌时,将 DW 成像加入钆塞酸增强 MR 成像中可提高胆管和肝脏侵犯的评估中的敏感度。